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INTRODUCTION
Over the last thirty years, once abundant wild salmon populations in
the Pacific and Atlantic Oceans have declined to a mere fraction of their
historic levels. As of 2016, salmon populations in Washington State’s
Columbia River region are either failing to make any progress towards
recovery or showing very little signs of improvement; Puget Sound salmon
are only getting worse.1 In the Gulf of Maine, salmon populations dropped
from five-hundred spawning adults in 1995 to less than fifty adults in
1999.2 Atlantic salmon, Salmo salar, were first designated as
“endangered”3 in November 2000—the Fish and Wildlife Service (FWS)
expanded the listing nine years later to include critical habitat along the
coast of Maine as a result of little improvement to the population’s
numbers.4 In the Pacific Ocean, FWS classified four significant salmon
species as endangered for protection under the Endangered Species Act

* Juris Doctor Candidate, Seattle University School of Law 2018. I would like to extend thanks to
Professor Carmen G. Gonzalez for her valuable insight of the precautionary principle, her extensive
knowledge on environmental regulations in the United States, and her unwavering support of this
Note.
1. Governor’s Salmon Recovery Office, State of Salmon in Watersheds 2016, WASH. ST.
RECREATION & CONSERVATION OFF., http://stateofsalmon.wa.gov/governors-report-2016/ [https://
perma.cc/6F3J-FKWE].
2. Endangered and Threatened Species; Final Endangered Status for a Distinct Population
Segment of Anadromous Atlantic Salmon (Salmo salar) in the Gulf of Maine, 50 C.F.R. § 224.101
(June 19, 2009).
3. Pursuant to the ESA, the term “endangered” means any species which is in danger of
extinction throughout all or a significant portion of its range other than a species of the Class Insecta
determined by the Secretary to constitute a pest whose protection under the provisions of this Act
would present an overwhelming and overriding risk to man. 16 U.S.C. § 1532(6).
4. Atlantic salmon (Salmo salar), NOAA FISHERIES, http://www.fisheries.noaa.gov/
pr/species/fish/atlantic-salmon.html [https://perma.cc/P7BF-3HWM].
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(ESA) beginning in 1991;5 of the four, only one species has been upgraded
to the less severe “threatened” status.6 As a keystone species in the Pacific
Northwest, a healthy salmon population supports an entire ecosystem of
species including grizzly bears, bald eagles, and orca whales—all of which
have been or are considered endangered7—and as the salmon population
continues to decline, other species will follow suit.8 Protecting one of the
last great salmon ecosystems is a daunting task requiring the collaboration
of conservationists, policymakers, scientists, and many others.
In response to the global demand for salmon tripling since the 1980s
and the declining wild salmon population, farmed salmon and aquaculture
facilities have gained popularity in the United States.9 In 2013, farmed
salmon exceeded 70% of total salmon consumed globally.10 Furthermore,
the thirty-three hatcheries devoted to salmon production in the United
States have helped mask the low-level return of wild salmon returning
each year; scientists have recorded as little as 10% of Chinook salmon in
the fall spawning season were born in the wild.11 Biologist Rachel Johnson
qualified the situation well, stating:
[w]hen you use the raw fish counts, it looks like the population is
doing well. But if you look at the number of fish that are produced in
the wild and return to spawn in the wild, and you follow through the
5. The ESA currently protects four salmon species native to Puget Sound in Washington State:
Chinook (Oncorhynchus tshawtscha), Chum (Oncorhynchus keta), Coho (Oncorhynchus kisutch) and
Sockeye (Oncorhynchus nerka). In November 1991, the Sockeye salmon was first listed as
“endangered” in the Snake River; beginning in 1992, the Chinook salmon was listed as “threatened”;
in 1999, the distinct population segment of the Upper Columbia River spring run was listed as
“endangered”; beginning in 1999, Chum salmon was listed as “threatened.” Salmon Species Listed
Under the Federal Endangered Species Act, WASH. ST. RECREATION & CONSERVATION OFF.,
http://www.rco.wa.gov/salmon_recovery/listed_species.shtml [https://perma.cc/XP3B-M3LX].
6. The term “threatened” means any species that is likely to become endangered within the
foreseeable future throughout all or a significant portion of its range. 16 U.S.C. § 1532(20).
7. Endangered and Threatened Wildlife and Plants; Draft Revised Supplement to the Grizzly
Bear Recovery Plan, 78 Fed. Reg. 17,708-09 (Mar. 22, 2013); Determination of Certain Bald Eagle
Populations as Endangered or Threatened, 43 Fed. Reg. 6,230-33 (Feb. 14, 1978); NMFS: Endangered
Status for Southern Resident Killer Whales, 70 Fed. Reg. 69,903-12 (Nov. 18, 2005).
8. See Guido Rahr on Salmon Strongholds, TEDX TALK (Jan. 9, 2015),
https://vimeo.com/116385054 [https://perma.cc/J6HC-M9FD]; Guido Rahr, Why Protect Salmon,
WILD SALMON CTR., https://www.wildsalmoncenter.org/work/why-protect-salmon/ [https://
perma.cc/EGK2-Q3E8].
9. See Farmed Salmon, WORLD WILDLIFE FUND, http://www.worldwildlife.org/industries/
farmed-salmon [https://perma.cc/ZLD8-XZE9].
10. In 2013, Americans consumed 353,000 tons of the farmed salmon. See Brian Clark Howard,
Salmon Farming Gets Leaner and Greener, NAT’L GEOGRAPHIC (Mar. 19, 2014), http://news.
nationalgeographic.com/news/2014/03/140319-salmon-farming-sustainable-aquaculture/
[https://
perma.cc/7BWR-Q7AU].
11. See Tim Stephens, Hatchery Fish Mask the Decline of Wild Salmon Populations, U. CAL.
SANTA CRUZ (Feb. 8, 2012), http://news.ucsc.edu/2012/02/hatchery-salmon.html [https://perma.cc/
BL2T-DHUJ].
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cycle, you see that the wild fish don’t survive at a high enough rate
to replace their parents. So the habitat is not supporting a sustainable
wild population.12

Still, the shift to dependency on farmed salmon has not been enough
to replace the wild salmon runs.13 Innovation and technology in the prior
decade have led us to AquAdvantage—the first-of-its-kind, genetically
engineered salmon produced by AquaBounty Technologies, Inc.14 The
biotech company claims that AquAdvantage salmon is better for the
environment and for consumers, while also boasting a low-impact fish
farming system that may result in healthier salmon.15 The new take on
traditional salmon aquaculture adds a growth hormone into the genetic
makeup of Atlantic salmon in order to accelerate the growth period from
three years to a swift eighteen months.16 Moreover, the AquAdvantage
salmon averages a final weight of 6,000 grams, almost a third heavier than
a wild Atlantic salmon.17 While AquaBounty implements farming
practices that improve upon the negative impacts of aquaculture and stock
ponds,18 the already endangered salmon population faces the risk of the
dominate AquAdvantage salmon compromising the Atlantic salmon’s
chance at survival.
The United States Food and Drug Administration (FDA) has asserted
authority to rule on and approve genetically engineered (GE) salmon by
classifying AquAdvantage as a “new animal drug.”19 Following an almost
twenty year review process, the FDA issued a Final Rule on November
24, 2015 granting the use of AquAdvantage salmon for sale in the U.S.20
Despite the fact that AquAdvantage has yet to be incorporated into the
market for consumption, environmental advocates wasted no time filing

12. Id.
13. The most recent report regarding the salmon returns to the Puget Sound area had mixed
reviews. While some areas were told to expect strong levels, others are closed to non-tribal fishing
until further notice. Despite the varying salmon returns across the state, the levels are still nowhere
near the historical levels and are being closely monitored. RYAN LOTHROP & MARK BALTZELL, WASH.
DEP’T FISH & WILDLIFE, 2017 PUGET SOUND SALMON FORECASTS: COHO AND CHINOOK (Mar. 01,
2017), http://wdfw.wa.gov/fishing/northfalcon/2017/2017_salmon_forecasts_fact_sheet.pdf [https://
perma.cc/EQW3-5TQW].
14. See Sustainable, AQUABOUNTY, https://aquabounty.com/sustainable/ [https://perma.cc/
SV7X-TV5G].
15. Id.
16. Id.
17. Id.
18. Id.
19. 21 C.F.R. § 510 (2015).
20. FDA Final Rule, New Animal Drugs in Genetically Engineered Animals, 80 Fed. Reg.
73,104 (Nov. 24, 2015).
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legal action to repeal the ruling.21AquAdvantage salmon has entered the
production phase and will be ready for sale in grocery stores by the end of
2017.22 Moving forward, the FDA has not been able to absolutely
guarantee that AquAdvantage salmon are safe to eat and severe
environmental degradation is likely to result from poor review of such a
product. The new field of GE food products must be approached with
caution and skepticism.
This Note seeks to address the issues concerning the FDA’s approval
of genetically modified salmon for consumption, arguing that the FDA did
not properly vet AquAdvantage salmon, as well as relied on inappropriate
criteria in their approval of its market use. Part I provides a brief history
of AquAdvantage salmon’s introduction to U.S. markets and the legal
actions taken in response to the FDA ruling. Part II discusses the statutes
and regulations fundamentally relevant to GE products, as well as a
critique of the way each regulation was used to approve AquAdvantage.
Part III offers a comparison to the European Union’s methods of tackling
GE regulation and details why the EU decided to ban AquAdvantage
salmon. Part IV offers an analysis of the current issues surrounding the
production of AquAdvantage salmon and explores the potential
consequences following the FDA ruling. This Note concludes with a
suggestion to parallel the U.S. regulatory system to the more succinct and
rigorous process the European Union relies on to regulate GE animals, a
system that operates under the precautionary principle. This Note will
recommend that the FDA adhere to the crucial precautionary principle to
ensure the effects of a new GE product, such as AquAdvantage, are safe
for the environment before the effects of an unknown product cause
irreversible damage.
I.

BACKGROUND: A HISTORY OF GE SALMON AND THE PUBLIC
RESPONSE

AquaBounty engineered a fast-growing, genetically engineered
salmon by combining DNA from three distinct species: Atlantic salmon,
deep-water ocean eelpout, and Pacific Chinook.23 Together, the three
21. Complaint for Declaratory and Injunctive Relief, Inst. For Fisheries Res. v. Burwell, No.
3:16-cv-01574 (N.D. Cal. March 30, 2016) [hereinafter Fisheries A]. The Inst. for Fisheries Resources
case has several pretrial motions that are cited to in this Note. To ensure clarity, each case has been
labeled with a letter to distinguish between the various motions.
22. AquaBounty Techs., Inc., Quarterly Report (Form 10-Q) (Mar. 31, 2017) https://
www.sec.gov/Archives/edgar/data/1603978/000160397817000035/aqb10-q2017x03x31.htm [https://
perma.cc/7H5X-ZCY6].
23. Genetically Engineered Salmon: What You Should Know, EARTHJUSTICE (Sept. 1, 2016),
http://earthjustice.org/features/what-you-should-know-about-ge-salmon?utm_source=crm&utm_
content=blurb&curation=newsletter [https://perma.cc/93EG-ARU4] (The scientific names for the
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species created a salmon that reaches maturity in half the time and is
significantly larger than its non-GE Atlantic salmon counterpart.24 The GE
salmon consists of a growth hormone gene from the Chinook salmon to
shorten the overall growth period and has been designed in a specific way
that renders the salmon 98.9% sterile.25
A.

The Development of AquAdvantage Salmon

In 1995, AquaBounty Technologies, Inc. submitted a proposal to the
FDA, spurring a twenty year review process before ultimately receiving
the approval last year to go forward with the production of AquAdvantage
salmon.26 Because AquAdvantage salmon is not a GE animal product
intended for use in pharmaceuticals,27 it is subject to approval as a New
Animal Drug Application (NADA).28 NADAs are submitted to the FDA
and the Center for Veterinary Medicine to be evaluated for safety.29
Previously under NADA, products such as tick control medication and
pain medication have been approved for use on dogs.30 No NADA
approved product has ever gone on to be consumed directly by humans in
the way AquAdvantage salmon would be. The AquAdvantage salmon is
the FDA’s first approval of a genetically engineered salmon for
three species used to create AquAdvantage salmon are as follows: Salmo salar, Macrozoarces
americanus, and Oncorhynchus tshawytscha. The Pacific Chinook salmon and the Atlantic are two
separate species of salmon.).
24. FDA Environmental Assessment, infra note 25, at 1; Jim Kozubek, FDA Decision Will Lead
to First Ever Genetically-Modified Animal for Consumption, TPM IDEA LAB (Oct. 10, 2011, 2:00
PM), http://talkingpointsmemo.com/idealab/fda-decision-will-lead-to-first-ever-geneticallymodifiedanimal-for-consumption [https://perma.cc/PZY2-EBK9].
25. CTR. FOR VETERINARY MED., U.S. FOOD & DRUG ADMIN., AQUADVANTAGE SALMON
ENVIRONMENTAL ASSESSMENT 101 (2015), https://www.fda.gov/downloads/AnimalVeterinary/
DevelopmentApprovalProcess/GeneticEngineering/GeneticallyEngineeredAnimals/UCM466218.pdf
[https://perma.cc/DJ7H-HVVS].
26. HAROLD F. UPTON & TADLOCK COWAN, CONG. RES. SERV., R43518, GENETICALLY
ENGINEERED SALMON (2015). For background, see id. at 8–10.
27. Pharmaceuticals are included under the definition of “drug” in the Food, Drug, and Cosmetic
Act. See 21 U.S.C. § 321(g)(1).
28. CTR. FOR VETERINARY MED., U.S. FOOD & DRUG ADMIN., GUIDANCE FOR INDUSTRY:
REGULATION INTENTIONALLY ALTERED GENOMIC DNA IN ANIMALS 15 (2017) https://
www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry
/UCM113903.pdf [https://perma.cc/D8U9-6R4L]. The current draft can be found at 82 Fed. Reg.
17,844. Originally, Guidance 187 was titled “Guidance for Industry: Regulation of Genetically
Engineered Animals Containing Heritable Recombinant DNA Constructs” and published in 2009. The
FDA has since renamed it and republished it to the Federal Register for public comment.
29. CTR. FOR VETERINARY MED., U.S. FOOD & DRUG ADMIN. FINDING OF NO SIGNIFICANT
IMPACT, AQUADVANTAGE SALMON (Nov. 12, 2015), https://www.fda.gov/downloads/Animal
Veterinary/DevelopmentApprovalProcess/GeneticEngineering/GeneticallyEngineeredAnimals/UCM
466219.pdf [https://perma.cc/9CQM-AXGS].
30. Recent Animal Drug Approvals, U.S. FOOD & DRUG ADMIN. (May 01, 2017), https://
www.fda.gov/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/ucm363948.htm [https://
perma.cc/4G43-AXP9].
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consumption in the United States and the only approved GE animal in the
world considered safe enough to eat.31
By 2009, AquaBounty provided the FDA with all of the necessary
studies and in the following year, the NADA was officially evaluated by
the agency to determine whether the new drug is safe and effective for its
intended use.32 On September 3, 2010, the FDA declared AquAdvantage
salmon safe for human consumption as wild Atlantic salmon.33 The FDA
released its environmental assessment and official finding that GE salmon
pose no significant risk to the environment on December 26, 2012, for
public comment.34 The assessment received more than 400,000 comments
during the comment period (largely opposing the FDA’s finding) but
within a few months, reached well over 1.5 million negative comments in
total.35 The concern expressed in those comments was not incorporated
into the Final Rule.
On November 19, 2015, a letter stating the approval for use of
AquAdvantage salmon was delivered to the CEO of AquaBounty
Technologies, Inc.36 and the Final Rule was published in the Federal
Register shortly after.37
B.

Environmental Advocates and Public Opposition

Two major environmental non-profit organizations are responsible
for generating public awareness and identifying the problems surrounding
AquAdvantage salmon: The Center for Food Safety38 and Earthjustice,39
31. FINDING OF NO SIGNIFICANT IMPACT, supra note 29.
32. GUIDANCE FOR INDUSTRY, supra note 28, at 13. Effectiveness of an article intended to alter
a characteristic of an animal is demonstrated by showing that the genetically engineered animal has
the claimed altered characteristic. Additionally, the FDA requires the manufacturer to submit studies
discussing the safety and effectiveness of the new animal drug and what risks it may pose to human
health and/or environmental health.
33. See Andrew Pollack, Modified Salmon is Safe, F.D.A. Says, N.Y. TIMES (Sept. 3, 2010),
http://www.nytimes.com/2010/09/04/health/policy/04salmon.html.
34. Draft Environmental Assessment and Preliminary Finding of No Significant Impact
Concerning a Genetically Engineered Atlantic Salmon; Availability, 77 Fed. Reg. 76,050 (available
for public comment Dec. 26, 2012) (codified at 80 Fed. Reg. 73,104).
35. Press Release, Earthjustice, Nearly 1.5 Million Objections to Genetically Engineered Salmon
Filed with FDA (Apr. 25, 2013) http://earthjustice.org/news/press/2013/nearly-1-5-millionobjections-to-genetically-engineered-salmon-filed-with-fda [https://perma.cc/WTK4-FD9F].
36. Bernadette M. Dunham, FDA, Letter to Dr. Ronald Stotish, AquAdvantage Salmon Approval
Letter and Appendix, NADA 141-454 (Nov. 19, 2015), https://www.fda.gov/
AnimalVeterinary/ucm466214.htm [https://perma.cc/7Q4B-PBYN].
37. FDA Final Rule, New Animal Drugs in Genetically Engineered Animals, 80 Fed. Reg. at
73,104.
38. CENTER FOR FOOD SAFETY, http://www.centerforfoodsafety.org/# [https://perma.cc/KAA7THYD].
39. EARTHJUSTICE, http://earthjustice.org (last visited May 30, 2017) [https://perma.cc/YATCEFD5].

2017]

Salmon with a Side of Genetic Modification

317

located in Washington, D.C. and San Francisco, respectively. The
organizations are two of the primary named plaintiffs in the lawsuit filed
against the FDA, joined by the Center for Biological Diversity, Friends of
the Earth, and Food and Water Watch.40 Both organizations involved have
not only brought a legal challenge to the AquAdvantage ruling but have
actively engaged the public to oppose the rule throughout the entire
twenty-year review process. To date, over two million people have
submitted comments in opposition to GE salmon.41
Critiques directed at the FDA and AquaBounty span far and wide,
from environmental advocates claiming that “[the] federal government
agencies are ill-equipped to handle genetically engineered animals”42 to
influential retailers announcing their refusal to stock the GE salmon out of
concern for food safety and environmental impact to wild salmon runs.43
The national campaign launched by the Center for Biological Diversity
helped yield a large number of the public comments and signatures posted
to the Federal Register following the FDA’s decision.44 The Center for
Food Safety created a platform for grocers, restaurateurs, and other food
suppliers to pledge against buying, selling, or serving genetically
engineered salmon in their establishments.45 Earthjustice continues to
oppose the ruling in court while also educating consumers about the food
safety concerns, the environmental impact, and the labeling issues
surrounding GE salmon.46 In addition to the millions of public comments
received opposing the issue, several news sources, as well as politicians
40. See Fisheries A, supra note 21.
41. See Genetically Engineered Salmon, supra note 23.
42. Brady Dennis, The FDA Just Approved the Nation’s First Genetically Engineered Animal:
A Salmon that Grows Twice as Fast, WASH. POST (Nov. 19, 2015) (quoting Dana Perls, food and
technology campaigner at Friends of the Earth), https://www.washingtonpost.com/news/to-yourhealth/wp/2015/11/19/the-fda-just-approved-the-nations-first-genetically-engineered-animal-asalmon-that-grows-twice-as-fast/?utm_term=.3ac90b4ffd70 [https://perma.cc/5DJU-J45F].
43. Madelyn Kearns, Here are the Retailers Who Won’t Sell AquaBounty’s GM Salmon,
SEAFOOD SOURCE (Nov. 23, 2015), http://www.seafoodsource.com/news/foodservice-retail/here-arethe-retailers-who-won-t-sell-aquabounty-s-gm-salmon [https://perma.cc/4KEF-6ZGJ].
44. See FDA Final Rule, New Animal Drugs in Genetically Engineered Animals, 80 Fed. Reg.
at 73,104
45. Press Release, Ctr. for Food Safety, Costco Will Not Sell GMO Salmon (Nov. 24, 2015)
http://www.centerforfoodsafety.org/press-releases/4141/costco-will-not-sell-gmo-salmon
[https://
perma.cc/3ATP-TK3Z]; see also Join the Campaign to Stop GE Fish, CTR. FOOD SAFETY,
http://www.centerforfoodsafety.org/issues/309/ge-fish/join-the-campaign-to-stop-ge-fish
[https://
perma.cc/ES5E-VG9K].
46. In July 2013, the New York Times conducted a poll of its readers asking their opinion on
whether GE food should be labeled in the grocery store. An overwhelming 93% of readers stated foods
should be identified and 75% expressed concern with genetically engineered foods. See Allison
Kopicki, Strong Support for Labeling Modified Foods, N.Y. TIMES (July 27, 2013)
http://www.nytimes.com/2013/07/28/science/strong-support-for-labeling-modified-foods.html. See
generally Genetically Engineered Salmon, supra note 23.
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on either side of the aisle, added their support for the environmental
advocates challenging the FDA.47 Senator Lisa Murkowski spoke out in
response to the FDA’s announcement of the final rule, stating that she was
“livid at the FDA’s announcement to approve genetically engineered
‘salmon’—what seems to be more science experiment than fish or food.”48
C.

Salmon’s Day in Court

The Center for Food Safety, Earthjustice, and other environmental
groups collectively filed a lawsuit challenging the FDA’s approval of
AquAdvantage salmon. They alleged that the Food, Drug, and Cosmetic
Act (FDCA) does not grant authority to the FDA to regulate GE animals.49
The plaintiffs challenged the validity of the 2009 Guidance for Industry
declaration, and claimed that it was inadequate on the grounds that “it fails
to consider environmental risks.”50 The claim also included a criticism of
the FDA for failing to conduct an environmental impact statement as
required by the National Environmental Policy Act (NEPA) to consider
the “risk that man-made salmon could escape from facilities, interbreed
with wild salmon, and compete with other animals for food and space.”51
The injunction against the FDA and the Fish and Wildlife Service was
filed on March 30, 2016 in the United States District Court for the
Northern District of California.52
Later, on August 30, 2016, the court granted the respondent’s motion
to dismiss on the grounds that a challenge may not be brought against
EPA’s “no effect” determination to endangered salmon because it was not
a final agency action.53 The court reasoned that the responses offered from
the government were not final action because they were “purely advisory
and lacked direct and appreciable legal consequences.”54 For the plaintiffs
to bring a claim under the Administrative Procedure Act, the action must
be a final agency action.55 The court went on to say that the “no effect”
47. See supra text accompanying note 46; see also William Yardley, Genetically Engineered
Salmon Is Fit For Dinner, FDA Says in First Decision of its Kind, L.A. TIMES (Nov. 19, 2015),
http://www.latimes.com/nation/la-na-sej-gmo-salmon-20151120-story.html [https://perma.cc/9AFCNBK3].
48. Yardley, supra note 47 (quoting U.S. Senator Lisa Murkowski).
49. See Fisheries A, supra note 21. The lawsuit was filed under the Administrative Procedure
Act, which grants a right of judicial review to a person suffering legal wrong because of agency action,
or adversely affected or aggrieved by agency action. 5 U.S.C. § 702 (1976).
50. Fisheries A, supra note 21, at 11, 12.
51. Id.
52. Id.
53. Order for Motion to Dismiss, Inst. for Fisheries Res. v. Burwell, No. 16-cv-01574-VC (N.D.
Cal. Aug. 30, 2016) [hereinafter Fisheries B].
54. Id. at 2.
55. 5 U.S.C. § 704. See generally Fisheries B, supra note 53.
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determination may be argued as an arbitrary and capricious value by the
plaintiffs at a future hearing, but that the claim was not valid in that
proceeding.56
Litigation has continued with U.S. District Court Judge Chhabria
delivering the most recent judgment on January 10, 2017.57 The court
granted the plaintiff’s motion to compel the government to produce
materials and documents related to the case, claiming that the
administrative record was incomplete.58 The judge concluded that no
privilege applied to the materials and documents; therefore, the
government must release all documents related to the agency’s approval
of AquAdvantage salmon.59 The significance of the decision is twofold—
the judicial system has signaled to agencies that they expect transparency
of their approval process; and the ruling opens the door for further
enforcement that proper evaluation of potential risks is completed before
approving future GE products.
II.

REGULATORY FRAMEWORK

Historically, Congress never considered the regulation of food
genetically engineered in labs; therefore, no designation was made for
which agency would hold proper jurisdiction to regulate GE products.
When engineered corn and other major crops were increasingly used, the
United States entered the era of biotechnology, and policymakers drafted
regulations to cover this scope of new foods.
A.

Regulatory Authority for the FDA

Biotechnology and the engineering of genetically engineered foods
became popular in the 1980s; this pressured the White House to create the
Coordinated Framework for Regulation of Biotechnology in 1986.60 The
Coordinated Framework identified three agencies—the U.S. Department
of Agriculture, the Environmental Protection Agency, and the U.S. Food
and Drug Administration—to share the regulatory responsibilities of
biotechnology; the FDA was charged with evaluating food safety issues
for all genetically engineered products.61 The legislation most importantly
56. Fisheries B, supra note 53, at 3.
57. Order to Compel Completion of Administrative Record Inst. For Fisheries Res. v. Burwell,
No. 16-cv-01574-VC (N.D. Cal. Jan. 10, 2017) [hereinafter Fisheries C].
58. Id. A complete administrative record includes all documents and materials directly or
indirectly considered by agency decision-makers.
59. Id.
60. Coordinated Framework for Regulation of Biotechnology, 51 Fed. Reg. at 23, 302 (June 26,
1986).
61. For the purposes of this Note, only the role of the FDA will be discussed in detail because
the roles assigned to the Dept. of Agriculture and the EPA do not include GE animals. Id. at 23, 303.
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states that GE products are not inherently riskier than their natural analogs
and, therefore, GE products can be adequately regulated by the preexisting statutory and regulatory structure.62
The category of genetically engineered plants and animals was not
included in the original text outlining the scope of products subject to FDA
regulation. The term GE is applied to any plant, crop, or animal once their
genetic material has been modified using rDNA techniques to produce a
new trait, such as reaching a larger adult size or a faster growing rate.63
When GE crops began to appear on the market, the FDA relied on an
inventive interpretation of the FDCA to claim regulatory authority over
the new plant and crop products. Congress enacted the FDCA in 1938,
granting the FDA authority to oversee the safety of food, drugs, and
cosmetics.64 Specifically, the FDA relied on language in Section 409 to
regulate GE plants; the agency interpreted “food additives” to encompass
genetic material as part of the definition.65 The provision defines food
additives as “any substance intended for the use in food, that may
reasonably be expected to become a component of food, or that may
otherwise affect the characteristics of food.”66
Section 409 goes on to say that FDA approval is not required if the
food additive in question is “generally recognized among experts to be
safe under the conditions of its intended use.”67 In 1992, the FDA made its
position to industry regarding GE foods blatantly clear: the agency would
presume GE plants and crops to be “generally recognized as safe,”
releasing manufacturers from waiting for the official go-ahead from the
FDA before producing their GE products.68 This places an enormous
amount of trust in the industries to produce safe food that meet FDA
standards, instead of in the FDA to evaluate the food’s safety. To bridge
the regulatory gap between GE plants and GE animals, the FDA issued its
“Guidance for Industry 187: Regulation of Intentionally Altered Genomic
DNA in Animals” to assert primary authority over GE animals in the
United States based on logic utilized previously for GE plants and crops.69
The broad interpretation of terms for GE plants within the FCDA
opened the door for the FDA to extend its authority regulating GE animals,
specifically under the “new animal drug” provision. A “new animal drug”
62. Id. at 23, 306.
63. See GUIDANCE FOR INDUSTRY, supra note 28.
64. Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 (1938).
65. Id. § 393 (1938).
66. Id. § 393(s).
67. Id.
68. Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg. 22,984, 22,990
(May 29, 1992).
69. See GUIDANCE FOR INDUSTRY, supra note 28.
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is defined as “any drug intended for use in animals other than man;”70 the
term “drugs” is defined in the Act as “articles (other than food) intended
to affect the structure or any function of the body of man or other
animals.”71 These definitions, along with the classification of GE products,
provide the language the FDA uses to include GE animals within the scope
of its regulatory authority.72 Specifically, the rDNA techniques used on a
GE animal product to alter the structure or function of the natural animal,
regardless of the intended use of products that may result from the
production of the GE animal, satisfies the definition of “drug;”73 analogous
to the application implored by the FDA in order to regulate GE plants, the
agency stretched the regulation’s language to work for industry
applications.
A new animal drug will not be considered safe by the FDA until it
has approved a NADA, which will determine whether the new animal drug
is safe and effective for its intended use.74 The FDCA determines that the
safety of a new animal drug is only within “reference to the health of man
or animal” and “environmental effects that directly or indirectly affect the
health of humans or animals.”75 AquaBounty received approval of its
NADA along with an official notice approving AquAdvantage in
November 2015.76 The standard of review does not address negative
implications to the environment unless a direct risk to man exists, nor does
it provide opportunity for the public to comment on the NADA or even be
aware of its filing.77 When the district court issued a ruling to produce the
materials the FDA used in its review process, it was intending to address
this exact concern.78
When the FDA claimed regulatory authority over AquAdvantage
salmon through the new animal drug definition, the agency effectively laid
claim on any subsequent GE animal applications in the future. The critique
of the FDA’s conduct is intended to expose the negative details of the
current GE approval process, as well as highlight the alarming issue of the
70. 21 U.S.C. § 393(v).
71. Id. § 321(g).
72. Id.
73. GUIDANCE FOR INDUSTRY, supra note 28, at 6.
74. GUIDANCE FOR INDUSTRY, supra note 28, at 13. Effectiveness of an article intended to alter
a characteristic of an animal is demonstrated by showing that the genetically engineered animal has
the claimed altered characteristic.
75. OFFICE OF SCI. & TECH. POLICY, EXEC. OFFICE OF THE PRESIDENT, CASE STUDY NO. 1:
GROWTH-ENHANCED SALMON 14 (2001), https://clintonwhitehouse5.archives.gov/media/pdf/
salmon.pdf [https://perma.cc/8U2H-HBVQ].
76. FDA Final Rule, New Animal Drugs in Genetically Engineered Animals, 80 Fed. Reg. at
73,104.
77. Id.
78. See Fisheries C, supra note 57.
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FDA setting poor precedent for reviewing future GE animal products.
First, the FDA acted quickly to regulate GE animals and, in doing so, was
able to create its own set of standards with the goal of approving
AquAdvantage. That set of standards will translate as the accepted policy
for GE animal applications, creating a greater entanglement of problems
in the future if the fundamental issues are not addressed. Second, when
presented with a first of its kind GE application, the proper protocol for
the FDA would be to table the application and craft the appropriate
regulatory scheme, including consultation requirements to the appropriate
agencies, before working through the application. Instead, the FDA chose
to fashion its regulation around an application and a specific set of
circumstances with very little thought to its effect in the future. The FDA
ultimately is risking our natural food system, a variety of crucial
environments, and human health.
B.

The National Environmental Policy Act

In 1970, Congress enacted NEPA to encourage productive and
enjoyable harmony between humans and the environment, to promote
efforts that prevent or eliminate damage to the environment and biosphere,
and to enrich the understanding of the ecological systems and natural
resources important to the nation.79
Under NEPA requirements, the FDA is obligated to coordinate with
any agency whose jurisdiction might be affected by the approval of a
NADA and ultimately the GE animal,80 unless the FDA included NEPA
requirements in its initial review.81 There are four general principles that
the FDA’s review would need to include: (1) whether the genetically
engineered animal poses any threats to humans, animals, or the
environment; (2) whether, in the event of a release, the genetically
engineered animal poses any more environmental threat than the nongenetically engineered equivalent; (3) whether the disposal of genetically
engineered animals poses any threats to humans, animals, or the
environment; and (4) whether any other safety issues remain unaddressed
by the sponsor.82
Under NEPA, a new animal drug applicant is then required to submit
an Environmental Assessment (EA) to the agency; the agency will rely on
the assessment to determine how an approved product would impact the

79. 42 U.S.C. § 4321 (1970).
80. 21 C.F.R. § 25.15(b) (2015).
81. GUIDANCE FOR INDUSTRY, supra note 28, at 7.
82. Id. at 8.
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environment.83 An EA can result in two major findings: either the product
is categorically excluded, which would be preferred by the FDA as it ends
their commitment to NEPA84 or a possibility of significant risk of adverse
environmental impact, which would require the FDA to submit to a more
rigorous review process and complete an environmental impact
statement.85
The EA for AquAdvantage salmon was issued, ending the
requirement for ongoing consultation with NEPA. The agency reached its
conclusion that there was no significant impact based on evidence that
failed to address the many problems with AquAdvantage salmon. The
FDA originally classified AquAdvantage salmon as having a “may effect”
determination and adjusted the status to “no effect” upon receiving an
informal suggestion from Fish & Wildlife to do so.86 Aside from this
suggestion, it is unclear how the “no effect” determination was reached;
Judge Chhabria expressed his confusion over the determination by
hypothesizing that the agency could have been looking for a way to avoid
further obligation to complete the consultation with the FDA.87 Until
recently, the FDA has adamantly refused to provide details of the
AquAdvantage approval process and its reasoning for allowing the project
to move forward.88 The recent order to release materials and documents
related to the approval of AquAdvantage salmon will begin to provide
insight on why the agency acted as it did, and will further provide answers
to the questions surrounding the no effect determination.89 Those materials
and documents become crucial to understanding the faults in the current
approval process and play a significant role in successful litigation.
Furthermore, the impending agency budget cuts will hinder its ability
to produce scientific reports and necessary environmental assessments. If
agency funding is drastically reduced, as proposed by the current

83. Typically, an EA will address any area that has a potential to affect the environment and
provides evidence or analysis done by the applicant that the agency may review. Most applications
will also include mitigation strategies to lessen any environmental impact and present alternatives to
the proposed plan of action. 21 C.F.R. § 514.1(b)(14) (2015).
84. Id. at § 25.33 (2015).
85. Id. at § 25.40. See generally 21 C.F.R. § 25.15 (2015).
86. Fisheries B, supra note 53, at 1. To be classified as “no effect,” the agency is signaling that
the product will not significantly affect the human environment. The agency fills out a Finding of No
Significant Impact (FONSI) document briefly stating its reasoning and determines that there is no need
for an environmental impact statement. In contrast, a “may effect” determination moves the agency
forward in conducting further studies about the environmental impact the product may have and how
significant the impact is. 21 C.F.R. § 25.41 (1997).
87. Fisheries B, supra note 53, at 3.
88. Id.
89. Fisheries C, supra note 57.
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presidential administration,90 the United States will continue to approve
threatening products and move blindly into the consequences from those
decisions.
C.

Endangered Species Act

Since its enactment in 1973, the ESA has been the cornerstone of
conservation efforts to preserve animals, plants, and ecosystems in the
United States.91 The ESA’s primary objectives are to prevent species
extinction and facilitate the recovery of listed species, while striving to
maintain healthy ecosystems and a vast network of biological diversity.92
The U.S. Fish and Wildlife Service and the National Marine
Fisheries Service (together, the “Services”) oversee and manage the listed
plants or animals and marine species, respectively.93 When a species is
considered for listing, the Services use two categories, threatened or
endangered, to make its final determination for each particular species.94
The ESA defines an endangered species as one that is in danger of
extinction throughout all or a significant portion of its habitat range, while
a threatened species is one that is likely to become endangered in the
foreseeable future.95 Once federal protection has been extended to a
species, the Services will designate critical habitat boundaries, a recovery
plan, and any other necessary protections that will aide in the species’
revival.96 To date, the ESA has succeeded in restoring a remarkable 99%
of the species listed, making it one of the most effective pieces of
environmental legislation in history.97
As stated in the introduction of this Note, the Atlantic salmon was
first listed as endangered on November 17, 2000.98 The Services identified
90. Press Release, The White House Office of the Press Secretary, Press Briefing by OMB
Director Mick Mulvaney Previewing the President’s FY18 Budget, (Mar. 15, 2017, 11:27 AM)
https://www.whitehouse.gov/the-press-office/2017/03/16/press-briefing-omb-director-mickmulvaney-previewing-presidents-fy18 [https://perma.cc/VNL7-XESF]; see also Hiroko Tabuchi,
What’s at Stake in Trump’s Proposed E.P.A. Cuts, N.Y. TIMES (Apr. 10, 2017), https://
www.nytimes.com/2017/04/10/climate/trump-epa-budget-cuts.html?_r=0.
91. Endangered Species Act, 16 U.S.C. §§ 1531–44 (1973).
92. Id. § 1532(3).
93. Id. § 1537 (8)(A).
94. Id. §§ 1531–44.
95. Id. § 1532(6).
96. SARAH MATSUMOTO ET AL., EARTHJUSTICE & ENDANGERED SPECIES COALITION, CITIZEN’S
GUIDE TO THE ENDANGERED SPECIES ACT, 18–24, (2003) [hereinafter CITIZEN’S GUIDE],
http://earthjustice.org/sites/default/files/library/reports/Citizens_Guide_ESA.pdf [https://perma.cc/
KPE4-7A76].
97. Robert B. Semple, Jr., The Law that Saved the Bald Eagle, N.Y. TIMES (Dec. 31, 2013)
reprinted in A WILD SUCCESS: AMERICAN VOICES ON THE ENDANGERED SPECIES ACT AT 40 2 (Feb.
2014), http://www.biologicaldiversity.org/campaigns/esa_wild_success/pdfs/A_Wild_Success.pdf
[https://perma.cc/7SZC-TW7R].
98. See 50 C.F.R. § 224.101 (2009).
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the Gulf of Maine as critical habitat for salmon due to its quality spawning
grounds.99 Coincidentally, the designated habitat overlaps with the
location of AquaBounty’s production facilities in southeastern Canada.
The location has prompted a majority of the criticism directed at
AquAdvantage salmon because it poses adverse risk to a critically
endangered species; the significance of the production location to the
endangered salmon population will be discussed in detail in section IV.
Section 7 of the ESA designates the responsibility to consult with
either FWS or NOAA fisheries whenever a federal agency is authorizing
a rule that may impose harm to endangered or threatened species.100 This
provision is crucial to protecting sensitive species from any future activity
that could adversely affect individuals or their designated critical habitat.
The principal takeaway from this section of the ESA is the conservation
provision which requires the agency, with the help of the Services, to
develop a biological opinion and plan that will preserve listed species from
harmful conduct.101 Ultimately, the agency is charged with the
responsibility to insure that any action authorized, funded, or carried out
is not likely to jeopardize the continued existence of any endangered
species or threatened species, or result in the destruction or adverse
modification of habitat of such species.102 The biological opinion is meant
to act as guidance for rule makers to conform agency action to the
parameters of endangered species.
The take prohibition in Section 9 outlines one of the enforcement
clauses provided by the ESA.103 Take is defined as “to harass, harm,
pursue, hunt, shoot, wound, kill, trap, capture, or collect, or attempt to
engage in any such conduct” to any individual or population of an
endangered or threatened species.104 Other interpretations have expanded
this definition to include not only direct harm to the species, but also
indirect harm by impairing the habitat in a way that may cause death or
injury by disrupting feeding, breeding, or essential behavior patterns.105
On several occasions, the Supreme Court has upheld the Services
determination of harm106 stating, “the ESA’s prohibition against harming
a species included habitat destruction severe enough to adversely affect a

99. Id.
100. CITIZEN’S GUIDE, supra note 96, at 29.
101. 16 U.S.C. § 1536 (1973).
102. Id. § 1536(a)(2).
103. Id. § 1538(1)(A)–(D).
104. Id. § 1532(19).
105. See CITIZEN’S GUIDE, supra note 96.
106. Babbitt v. Sweet Home Chapter of Cmtys. for a Great Or., 515 U.S. 687 (1995).
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listed species as a whole” and, as a result, industry challenges to this
definition have failed.107
If AquaBounty follows through with their production plans, their
actions most certainly will constitute a takings claim with respect to the
harm caused to the endangered Atlantic salmon populations in Maine.
Once a species has been listed on the ESA, the protections in place do not
allow for any harm to be inflicted upon the species; evidence of disrupted
breeding patterns or death to one individual will trigger the statute’s
safeguards and immediately result in a violation. The failure to account for
the outward harm to endangered salmon and their designated habitat is a
major oversight and will most certainly result in lawsuits once harm is
inflicted. The Atlantic salmon populations face immediate danger if
AquaBounty’s facilities on Prince Edward Island, Canada are built;108 if
successful, AquaBounty may eventually build facilities in the Pacific
Northwest, placing the four populations of endangered salmon at risk.
III.

ACROSS THE STOCK POND: THE EU REGULATORY STRUCTURE

In 2001, the European Council adopted Directive 2001/18/EC on the
Deliberate Release of Genetically Modified Organisms.109 Pursuant to
Article IV, applicants are required to apply and submit an environmental
risk assessment in order to gain the Council’s approval for use of GE
products, as well as submit an application to each Member State in which
they wish to market genetically modified products.110 The Member States
will then designate competent authorities to examine notifications of GE
products, and establish inspection measures.111 Applicants must also be
able to ensure traceability of marketed products. Subsequent to the
Directive Order, debates arose all over Europe regarding GE corn and soy
bean products, which were largely focused on labeling requirements and
fighting the negative public opinion regarding GE products.112 Directive
107. Palila v. Haw. Dept. of Land & Nat. Res., 639 F.2d 495, 497 (1981). Following Palila, the
Secretary of Interior issued a new definition of harm that included habitat modification that injures
wildlife by impairing essential behavioral patterns such as breeding, feeding, or sheltering, which has
become the widely accepted definition of a taking.
108. See infra note 159 (discussing the impacts on Canadian salmon populations).
109. 2001 O.J. (L 106) 1. This Directive not only states the EU policy on genetically modified
organisms in the environment but also repeals the previous Directive from 1990 (90/220/EEC).
Furthermore, the EU materials use the phrase GMO, instead of GE, when discussing these products.
For consistency and clarity I have edited all terms to be “GE” unless directly quoting EU documents.
110. Id. These Member States have the right to object to such marketing within their countries’
borders, based on where the testing will occur. Pursuant to Article 16, any EU Member State may
“provisionally restrict or prohibit the use of sale of a product if it has justifiable reason that an approved
product poses a risk to human health or the environment.”
111. Id. (L 106) 6.
112. In 1994, a British company began to market genetically modified canola oil and met severe
backlash during its approval process before gaining approval in 1997. See David Vogel & Diahanna
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2001/18/EC further requires consultation with its scientific risk agency in
cases where a competent authority raises objections regarding the risks of
the GE product to human health or the environment, and in which the
assessment report of the authority that received the notification indicates
that the GE product should not be released onto the market.113
The European Food Safety Authority (EFSA) is an agency in the EU
that provides independent scientific advice and comments on existing and
emerging risks to food safety. The EFSA published guidance on the
environmental risk assessment of GE animals, which provided
information for applicants and risk assessors on how to conduct an ERA
of living GE animals placed on the EU market.114 The document outlines
three primary aspects that should be included for a thorough risk
assessment: (1) applicants must complete a six-step assessment procedure
that will identify potential hazards and the extent of human, animal, and
environmental exposure to them, consistent with EU legislation; (2)
applicants must address seven areas of potential risk for GE animals; and
(3) applicants must consider viable alternatives, including cross-cutting
considerations, surrogate animals, and recommendations specific to the
environment into which GE animals are likely to be released.115 This
process ultimately includes a comment period and consideration of the
societal and economic aspects of approving a GE animal in the EU;
however, the EFSA solely examines the risk factor of the decision.116
The fundamental theme throughout the EU’s regulatory system is the
precautionary principle, an approach that guarantees a high standard of
environmental protection through preventative decision-making in the
case that risks are reasonably suspected.117 Encouragement for nations to
adopt the precautionary approach is well established in the UN Global
Compact. Rio Principle 7 specifically addresses the importance of

Lynch, The Regulation of GMOs in Europe and the United States: A Case-Study of Contemporary
European Regulatory Politics, COUNCIL ON FOREIGN REL. 9–11 (Apr. 5, 2011),
http://www.cfr.org/agricultural-policy/regulation-gmos-europe-united-states-case-studycontemporary-european-regulatory-politics/p8688 [https://perma.cc/6RWF-NWVV]. Additionally,
corn and soybean crops met opposition in the late 1990s for similar reasons. Id. at 10.
113. Directive 2001/18/EC at (L 106) 14.
114. Genetically Modified Animals, EUR. FOOD SAFETY AUTH., https://www.efsa.europa.eu/
en/topics/topic/gmanimals [https://perma.cc/ATF2-X5M4].
115. Id. In the second step, the EFSA expands on the seven potential risk areas they require
applicants to consider: (1) persistence and invasiveness of the GE animal, including vertical gene
transfer; (2) horizontal gene transfer; (3) interactions of the GE animal with target organisms; (4)
interactions of the GE animal with non-target organisms; (5) environmental impacts of the specific
techniques used for the management of the GE animal; (6) impacts of the GE animal on
biogeochemical processes; and (7) impacts of the GE animal on human and animal health. Id.
116. Id.
117. Commission White Paper on Precautionary Principle, COM(2000) 1 Final (Feb. 2, 2000).
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implementing preventative measures over remedial ones.118 The concept
of the precautionary principle is easily distinguished from what is known
as the principle of prevention because of the effort to apply caution to
scientific information that is either incomplete or inconclusive.119 In
contrast, the principle of prevention allows action first and reaction only
when something goes awry; currently, the United States operates under the
latter approach.120
The first formal inclusion of the principle was published in 2000 in
the European Commission’s documents, establishing the use of the
precautionary principle: “[W]here a full risk assessment is not possible,
measures should be based on the precautionary principle” and only applied
after the maximum possible scientific assessment of the risks.121 Within
the Communication are the guidelines for applying the principle to
regulation, stating that measures based on the precautionary principle
should be
[p]roportional to the chosen level of protection, non-discriminatory
in their application, consistent with similar measures already taken,
based on an examination of the potential benefits and costs of action
or lack of action (including, where appropriate and feasible, an
economic cost/benefit analysis), subject to review in the light of new
scientific data, and capable of assigning responsibility for producing
the scientific evidence necessary for a more comprehensive risk
assessment.122

In the case of GE products, the EU and its environmental agencies
have been able to gain a wider breadth of knowledge about how the
proposed animal or plant product will impact human health and the
environment, as well as provide a greater level of assurance to the EU
population that food is held to a high safety standard, despite its new
genetic makeup.

118. U.N. Conference on Environment and Development, Rio Declaration on Environment and
Development, U.N. Doc. A/CONF.151/26 (Vol. I), annex I (Aug. 12, 1992); see also The Ten
Principles of the UN Global Compact, Principle Seven: Environment, UNITED NATIONS GLOBAL
COMPACT [hereinafter Principle Seven], https://www.unglobalcompact.org/what-is-gc/mission/
principles/principle-7 [https://perma.cc/37J4-2QWA].
119. Principle Seven, supra note 118.
120. Arie Trouwborst, Prevention, Precaution, Logic and Law: The Relationship Between the
Precautionary Principle and the Preventative Principle in International Law and Associated
Questions, 2 ERASMUS L. REV. 105, 110 (2009).
121. Commission White Paper on Precautionary Principle, supra note 117, at 23–24.
122. Id. at 3.

2017]

Salmon with a Side of Genetic Modification

329

The United States and Canada remain the only two countries to
approve applications for AquAdvantage salmon.123 The former Chair of
the European Food Safety Authority GMO Panel spoke on the possibility
of AquaBounty filing for approval in the EU market following the FDA
approval for U.S. markets in 2015, expressing great concern for the notion
and holding the opinion that the GE salmon had not had the rigorous
review it ought to have been subjected to:
My view is that if an application were to be made for such GM
salmon to be released in Europe, then the risk assessment would
require considerably more data to demonstrate the efficacy of the
induced sterility in these GM salmon than were required by the Food
and Drug Administration.124

Health Canada, the Canadian agency equivalent to the FDA,
approved AquAdvantage salmon on May 19, 2016.125 In defending its
decision, the agency stated that the GE salmon is “identical to other farmed
salmon” and assured Canadians opposing the approval that their scientists
conducted a thorough analysis of all potential dangers.126 Similar to the
court proceedings currently underway in the U.S., several Canadian
environmental groups attempted to block AquaBounty, Inc., but were
unsuccessful in their efforts.127 These groups echoed the same concerns
that Earthjustice and the Center voiced in regards to escape and
endangerment to the endangered Atlantic salmon populations.128 As far as
the precautionary principle is concerned, Health Canada has faced legal
challenges to its past decisions on the basis that the agency has ignored its
commitment to utilize the precautionary approach.129 Petitioners to the
123. Andrew MacKendrick, Health Canada and Canadian Food Inspection Agency Approve
AquAdvantage Salmon, AQUABOUNTY (May 19, 2016), https://aquabounty.com/health-canada-andcanadian-food-inspection-agency-approve-aquadvantage-salmon/ [https://perma.cc/6RM3-UW6H].
124. Sarah Knapton, First Genetically Modified Salmon Cleared to Enter Human Food Chain,
TELEGRAPH UK (Nov. 19, 2015) (quoting Dr. Joe Perry), http://www.telegraph.co.uk/news/
science/science-news/12006398/First-genetically-modified-salmon-cleared-to-enter-human-foodchain.html.
125. Press Release, Health Canada, Health Canada and Canadian Food Inspection Agency
Approve AquAdvantage Salmon (May 19, 2016), https://www.canada.ca/en/health-canada/news/
2016/05/health-canada-and-canadian-food-inspection-agency-approve-aquadvantage-salmon.html
[https://perma.cc/3F5V-EMWL].
126. Id.
127. Ann Hui, Genetically Modified Salmon Approved for Consumption in Canada, GLOBE &
MAIL (May 19, 2016), http://www.theglobeandmail.com/news/national/health-canada-approvesgenetically-modified-salmon-as-safe-for-consumption/article30094235/
[https://perma.cc/W69RNUXW].
128. Food & Agric. Org. of the U.N., Guideline for the Conduct of Food Safety Assessment of
Foods Derived from Recombinant-DNA Animals, U.N. Doc. CAC/GL 68-2008 (2008).
129. Brief for Petitioner, Woodcock v. Health Canada, Env. Petition No. 289 (2009)
http://www.oag-bvg.gc.ca/internet/English/pet_289_e_33553.html [https://perma.cc/68DH-W3BK].
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Auditor General of Canada allege that Health Canada clearly abandoned
its promise to adopt the precautionary principle in many recent decisions,
including the decision to approve AquaBounty’s GE salmon.130
IV.

A NEW APPROACH TO THE REGULATION OF GE ANIMALS

The approval process the FDA relies on to regulate GE products has
led us to a market that includes AquAdvantage salmon and opened the
door for any number of GE animal products to enter the market in the
future. As many environmental groups and health advocates have argued,
the regulatory system needs to (1) consist of a more comprehensive
consultation with the appropriate environmental agencies; (2) include a
more robust use of the best available science that analyzes adverse impacts
a product may cause; and (3) take a conservative approach when ruling on
a proposed GE animal. Two leading biologists published a comment on
the Federal Register, stating that they had “found major scientific
inadequacies in this EA that set an unacceptably low bar for the scientific
basis of future EA or EIS documents” and further expressing concern for
the future approval of GE animals with “more ecologically disruptive
traits.”131 This Note proposes a change to the FDA approval process that
aligns with the EFSA requirements and includes a strategy that U.S.
environmental legislation is already familiar with.
A.

The Precautionary Principle

As discussed above, the core of the EU regulatory framework for
environmental matters is the precautionary principle, a concept that aims
to prevent harm before it occurs; prevention is key to enacting effective
environmental legislation considering most of the injury sustained is
permanent and not easily remedied with money. In contrast to the EU
framework, the precautionary principle appears only a handful of times in
U.S. regulation. For example, the FDCA bans the use of any food additive
if tests reveal that it caused cancer in either laboratory animals or humans
on the grounds that such chemicals could cause irreversible harm to
consumers.132

Health Canada has received official petitions to their environmental division, and this one in particular
alleges that Health Canada is not adhering to the precautionary principle.
130. Id.
131. Anne Kapuscinski & Fredrik Sundström, Comments on Docket No. FDA-2011-n-0899
Draft Environmental Statement for AquAdvantage Salmon and Prelim Finding of No Significant
Impact, Dated 4, SEMANTIC SCHOLAR (2013), https://pdfs.semanticscholar.org/b803/
22d30525c8fa85e5d7270e179b2b920eb0e5.pdf?_ga=2.215775572.233515052.15005276491344995263.1500527649 [https://perma.cc/ZR83-N6EC].
132. 21 U.S.C. § 348(c)(3)(A) (2012).
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Successively, the EPA uses the principle in the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA) to restrict the sale, distribution,
or use of any pesticide unless granted express approval prior to entering
the market.133 Before the EPA may authorize a pesticide, the claimant must
show that using the pesticide will not result in unreasonable, adverse
effects on the environment.134 In 1996, the Food Quality Protection Act
(FQPA) was amended to require the re-examination of pesticides under its
new risk-based registration, specifically to identify potential impacts
resulting from the use of pesticides.135 The FQPA marks the accepted use
of the precautionary approach for risk management and the reliance on
best available scientific data to approve use only if “there is a reasonable
certainty that no harm will result,” adding a great deal of protection to the
environment.136 Congress enacted the above policies to shift the burden of
proof to industry; Congress did so to require industry to prove the safety
of their products in order to prioritize a healthy environment and to slow
the degrading effects to the global environment. By only reacting to
environmental disasters instead of preventing injury, we have effectively
expedited the negative implications to our environment.
B.

A Case Study

When utilized, the precautionary principle is one of the most robust
clauses in environmental legislation; it justly imposes a duty upon the
industry and individual manufacturer to prove its product poses no
significant threat or risk of safety to consumers and the environment. A
precautionary approach toward risk regulation was enforced through
several modern-era judicial decisions. Ethyl Corp. v. EPA marks the
cornerstone interpretation of how the precautionary principle has an
impact on industry; the court in Ethyl Corp. ruled that preventing harm is
within the agency’s discretion when significant risk exists.137 As upheld
consistently by federal courts, “where existing methodology or research in
a new area of regulation is deficient, the agency necessarily enjoys broad
discretion to attempt to formulate a solution to the best of its ability on the

133. 7 U.S.C. § 136(a) (1996).
134. The term “unreasonable adverse effects on the environment” is defined as (1) any
unreasonable risk to man or the environment, taking into account the economic, social, and
environmental costs and benefits of the use of any pesticide, or (2) a human dietary risk from residues
that result from a ruse of a pesticide in or on any food inconsistent with the standard under section
346(a). Administrator is also required to consider the risks and benefits of pesticide exposure. Id. §
136(b).
135. 7 U.S.C. § 136a(c)(2)(B)(v) (1996).
136. 21 U.S.C. § 346a(b)(2)(A)(ii) (2012).
137. Ethyl Corp. v. Environmental Protection Agency, 541 F.2d 1 (D.C. Cir. 1976).
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basis of available information.”138 The ruling in Ethyl Corp. certainly
extends to the situation arising around AquAdvantage salmon; GE animals
are a previously unregulated area of law and contradicting science
suggests that serious negative side effects exist—calling on the agency to
take a precautionary approach.139 To rule on removing lead from gasoline,
the court reached its conclusion by weighing public interest against the
gasoline company’s interests, effectively lowering the proof of harm the
EPA was required to demonstrate.140 Ethyl Corp. established the need to
allow environmental agencies to act preventatively while regulating
industry, stating, “[a]waiting certainty will often allow for only reactive,
not preventative, regulation.”141 Another court followed the example set
out by Ethyl Corp. and held in Sierra Club v. Sigler that if “an agency is
evaluating significant adverse effects on the human environment in an
environmental impact statement and there are gaps in relevant information
or scientific uncertainty, the agency shall always make clear that such
information is lacking or that uncertainty exists.”142 Sigler gave way to the
interpretation that the environmental impact provision of NEPA also
required a worst-case analysis on the grounds that it was needed to assist
decision-making when scientific uncertainty exists.143
Where there are threats of irreversible damage, a rule based on a lack
of full scientific certainty should not be used as justification for postponing
cost-effective measures, thus accelerating further environmental and
public health degradation. In the case of AquAdvantage salmon, the full
review of the product was not completed to the extent required by
environmental agencies.144 This is in part due to the fact that the FDA is
simply unfit to rule on the safety of animals; their interpretation that
AquAdvantage salmon qualified as a new animal drug was inappropriate,
seeing as this specimen is a new species entirely. Moving forward, the
FDA must either adopt a system that better analyzes and studies an
applicant’s product—akin to the precautionary principle—or repeal its
regulatory authority over GE animal species. As is, the regulatory structure
will lead to devastating effects to our ecosystems, our citizens’ health, and
our natural resources.

138. Id. at 27.
139. Id.
140. Id. at 54.
141. Id. at 25.
142. Sierra Club v. Sigler, 695 F.2d 957, 969 (5th Cir. 1983).
143. Vogel & Lynch, supra note 112, at 4.
144. Fisheries A, supra note 21.
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Remaining Questions

While AquaBounty has addressed some of the major criticisms and
taken steps to prevent escapes into wild salmon runs, a number of
unanswered questions remain as the project moves forward. First and
foremost, AquaBounty has failed to consider that salmon escapes are still
a significant possibility.145 If GE salmon escape into wild streams and
rivers, there is no recapture plan in place by AquaBounty and it is nearly
impossible to recover those individuals.146 The intermixing of the two
distinct salmon species will create competition for resources that the larger
GE salmon will easily win; the FDA believes that this is not an unlikely
situation.147 While the two facilities of production are currently in Panama
and southeastern Canada,148 AquaBounty has spoken on several occasions
of its intent to open multiple facilities in the United States. On June 13,
2017, AquaBounty acquired its first U.S. fish farm in Albany, Indiana; the
facility will support a capacity of 1,200 metric tons of salmon per year.149
The company expects its first harvest from the Indiana site to be ready by
late 2019.150 The company is moving quickly to establish its presence in
U.S. grocery stores,151 and it is inevitable that GE salmon will come closer
to our vulnerable wild populations if production continues to proceed.
Regardless, AquaBounty has already incurred environmental safety
violations with only two land-based facilities in operation.152 In 2014,

145. See generally Rosamond Naylor et al., Fugitive Salmon: Assessing the Risks of Escaped
Fish from Net-Pen Aquaculture, 55 BIOSCIENCE 427–37 (May 1, 2005).
146. Brettny Hardy, What Will Happen When Genetically Engineered Salmon Escape Into the
Wild?, EARTHJUSTICE (Apr. 08, 2016), http://earthjustice.org/blog/2016-april/what-will-happenwhen-genetically-engineered-salmon-escape-into-the-wild [https://perma.cc/3W65-T9PK].
147. FDA Final Rule, New Animal Drugs in Genetically Engineered Animals, 80 Fed. Reg. at
73,104. See generally Naylor, supra note 145.
148. Questions and Answers on FDA’s Approval of AquAdvantage Salmon, U.S. FOOD & DRUG
ADMIN. (Dec. 21, 2015), http://www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/
GeneticEngineering/GeneticallyEngineeredAnimals/ucm473237.htm
[https://perma.cc/9W5JPTQS].
149. Press Release, AquaBounty, Inc., AquaBounty Acquires Fish Farming Facility in Indiana
(June 13, 2017), http://phx.corporate-ir.net/phoenix.zhtml?c=197553&p=irol-newsArticle&ID=
2280501 [https://perma.cc/4HAN-HCR2]. AquaBounty purchased facilities from Bell Fish Company
for $14 million dollars.
150. Id.
151
As of August 4, 2017, Canadian grocery stores began selling AquAdvantage salmon without
labeling or otherwise distinguishing the product from non-GE salmon. Jenna Gallegos, GMO Salmon
Caught in U.S. Regulatory Net, but Canadians have eaten 5 tons, WASH. POST (Aug. 4, 2017) https:/
/www.washingtonpost.com/news/speaking-of-science/wp/2017/08/04/gmo-salmon-caught-in-u-sregulatory-net-but-canadians-have-eaten-5-tons/.
152. AquaBounty Fined for Repeated Environmental Violations on Genetically Engineered
Salmon, FOOD & WATER WATCH (Oct. 28, 2014), http://www.foodandwaterwatch.org/news/
aquabounty-fined-repeated-environmental-violations-genetically-engineered-salmon
[https://
perma.cc/95CY-GW39].
Original
document
available,
in
Spanish,
at:
http://
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Panamanian officials fined the company for water discharge violations and
failing to address a storm-related incident that led to lost salmon.153
Wenonah Hauter, the Executive Director for Food and Water Watch, made
the following statement in the organization’s release of the safety report,
“FDA has always assured the public that it is checking, monitoring and
regulating AquaBounty’s production platform to ensure the company can
mitigate the well-documented environmental impacts of escaped GE
salmon . . . AquaBounty is unwilling or unable to follow basic rules and
regulations, and FDA is unable to enforce them.”154 Furthermore, the FDA
expressly stated in its Finding of No Significant Impact report that it did
not consider the impacts that either facility would have on the surrounding
environment and only granted the application because production would
not occur on U.S. soil.155
Second, while the AquAdvantage salmon are treated to create sterile
individuals, the methods are only about 97% effective.156 When the
remaining 3–5% is stacked up to the hundreds of thousands of eggs
AquaBounty plans to produce, thousands of fish will be left fertile; this
failure to render 100% of its stock sterile creates a greater risk to an already
fragile wild salmon population.157 Finally, whether the claim that GE
salmon is actually healthier for human consumption than wild salmon is
split by contradicting research; biologists maintain the position that there
is little research showing that long-term consumption of fish with added
growth hormones is completely safe for humans, while AquaBounty
insists the AquAdvantage salmon is a healthier choice. Over the last few
decades, reports ranging from the reproductive risks of chemicals in
sunscreens to the carcinogens in pesticides applied to crops have been
presented to the public; this demonstrates the necessary research of a
product to ensure safety before use is routinely omitted from legislative
requirements. In these cases, opposition from similar stakeholders had
been presented and ignored. The “wait and see approach” the FDA is
inclined to utilize for AquAdvantage salmon is not only unsuitable for
food but unsubstantiated by the record of past products assumed to be fine.
The threshold question for many scientists, consumers, and
environmental advocates opposing GE salmon asks whether the FDA
www.centerforfoodsafety.org/files/resolucion-arach-071_2014-sancion-a-aquabounty_53203.pdf
[https://perma.cc/9AKE-52KF].
153. Id.
154. Id.
155. FINDING OF NO SIGNIFICANT IMPACT, supra note 29, at 3.
156. Tillmann J. Benfey, Effectiveness of Triploidy as a Management Tool for Reproductive
Containment of Farmed Fish: Atlantic salmon (Salmo salar) as a Case Study, 8 REVS. AQUACULTURE,
264–82 (Sept. 2016).
157. Id.
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ruling has established a dangerous precedent for our food system and what
will follow next. By simply following the manufacturers’ claims of
greener methods and sustainable farming, we are buying into a sciencedriven food structure and allowing labs to create our nourishment.
Submitting to AquaBounty puts into question all other sources of protein
consumed in the US; will we now become accustomed to GE cows and
farms stocked with chickens three times their normal size?
Pursuant to the ESA and the take prohibition in Section 9, any species
of salmon listed under the ESA may not be exposed to foreseeable risks;
any caused harm is a direct violation of the ESA.158 In the immediate
future, Atlantic salmon are at risk of harm if the AquAdvantage salmon
raised near the Gulf of Maine escape into the bordering designated critical
habitat.159 Assuming AquaBounty will follow through with its plan to
build additional production facilities across the U.S., beginning in Indiana,
what is to say the four salmon species of the Puget Sound will not soon
experience the pressures of AquAdvantage salmon? Considering the
millions of consumers and retailers that are vocal about their opposition to
GE salmon, will this refusal to buy or sell anything but wild-caught salmon
add extra strains to the wavering wild salmon runs? The GE market poses
many direct and indirect effects to salmon populations that further put into
question the survival of the five endangered species in the U.S.
CONCLUSION
The salmon case study is a disturbing example of the key weakness
of the FDA’s approach but also serves as a great example of the strengths
of the precautionary approach. Public interest and the environment would
be better served by a policy shift and the granting of jurisdictional
authority to a more qualified agency, with the expertise to determine safety
of GE animal products, than the FDA. The precautionary principle is not
a novel idea to U.S. legislators; by adhering to the millions of people
opposing GE salmon and enacting the approach that ensures all
foreseeable and reasonable risks have been addressed, we are more likely
to have a healthy environment independent of engineered food sources.
The purpose of environmental law is to protect natural resources
even when uncertainty of the long-term effects exists. The lasting
158. See 16 U.S.C. § 1532(19) (1973).
159. The production facility in Canada will be located on Prince Edward Island in Ontario
County, which borders the state of Maine. According to the designated critical habitat for Atlantic
salmon (established in 2009), the boundary reaches the border shared with Canada and puts the
AquAdvantage salmon in close geographic proximity to the endangered Atlantic salmon. See
generally Atlantic Salmon Critical Habitat Map, NAT’L MARINE FISHERIES SERV. (2009),
http://www.nmfs.noaa.gov/pr/pdfs/criticalhabitat/atlanticsalmon.pdf
[https://perma.cc/C4ZARQDE].
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consequences of losing species, damaging habitat, and degrading human
health all grossly outweigh the benefits of cheaper production today.
AquaBounty does not present a solution to address the underlying problem
of species extinction caused by unsustainable fishing methods and
overfishing. The efforts being made to skirt around these issues ought to
instead be spent preserving the natural salmon resource, while still in
existence, and in doing so tackle the root of the problem. What needs to
happen now goes beyond bigger and faster-growing fish. The
AquAdvantage salmon case becomes another important cause to advocate
for,160 especially in light of a presidential administration dedicated to
rollback environmental measures.161 Failure to act on the approval of
AquAdvantage salmon places the United States atop a very slippery slope
that descends into a food system completely dependent on lab concoctions
and processing plants, all at the risk of a healthy environment. We cannot
manufacture an entire ecosystem to compensate for the impending damage
caused by allowing genetically engineered salmon now.

160. Press Release, United States Senate, Chairman Barrasso: The Endangered Species Act
Needs to be Modernized (Feb. 15, 2017), https://www.epw.senate.gov/public/index.cfm/2017/
2/chairman-barrasso-the-endangered-species-act [https://perma.cc/5CHQ-P9TW].
161. Press Release, The White House Office of the Press Secretary, Remarks by President Trump
at Signing of Executive Order to Create Energy Independence (Mar. 28, 2017), https://
www.whitehouse.gov/the-press-office/2017/03/28/remarks-president-trump-signing-executiveorder-create-energy [https://perma.cc/UHL6-XSV5].

